


















Khizrieva S. S., Vetrova E. V., Borisenko S. N., Maksimenko E. V., Borisenko N. I.
Chimica Techno Acta. 2020. Vol. 7, no. 4. P. 192–198.
ISSN 2409–5613
Synthesis and study of complexes of the novel 
Russian antiviral drug Camphecene with pentacyclic 
triterpenes of licorice
S. S. Khizrieva*, E. V. Vetrova, S. N. Borisenko, 
E. V. Maksimenko, N. I. Borisenko
Research Institute of Physical and Organic Chemistry, 
Southern Federal University, 
194/2 Stachki Ave., Rostov-on-Don, 344090, Russia
*email: hizrieva@sfedu.ru
Abstract. For the first time, the complexation of pentacyclic triterpenes of licorice 
(glycyrrhizic acid (GA) and its aglycone, glycyrrhetinic acid (GLA)) with the novel Russian 
antiviral drug Camphecene (Camph) was investigated. The complexes obtained at dif-
ferent molar ratios were studied using both UV/Vis spectroscopy and mass spectrometry 
(ESI MS). Formation of the host:guest complexes were registered: GA and GLA molecular 
complexes (Camph+2GA; Camph+2GLA) with stability constants К = 6.94 · 106 М–2 and 
К = 2.89 · 106 М–2, respectively. The research results demonstrate a considerable potential 
of ESI MS as a technique for simple and fast detection of formation of the complexes 
of GA /GLA and the novel drugs.
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Introduction
Influenza is known to be the most 
common and dangerous respiratory viral 
infection. It causes annual epidemics and 
pandemics, leading to significant increases 
in morbidity and mortality in all regions 
of the world. In connection with the grow-
ing number of cases of viral infections and 
especially resistant viral strains, it is nec-
essary to improve the available therapeu-
tic methods, complementing them with 
the discovery of new antiviral agents. On 
the other fist, it is widely recognized that 
the medical heritage of plants is a valu-
able resource for the treatment of infec-
tious disorders. This indicates a growing 
interest in antiviral products based on sec-
ondary plant metabolites [1–3]. The one 
of the unique plants used in both folk and 
traditional medicine is licorice. Licorice 
(Glycyrrhiza glabra L.) is one of the oldest 
and most widely used medicinal plants [4, 
5]. The major plant’s metabolite in licorice 
root is glycyrrhizic acid (GA, 1), pentacy-
clic triterpene, consisting of one residue 
of glycyrrhetinic acid (GLA, 2) and two 
residues of glucuronic acid (Fig. 1).
Licorice triterpenes 1 and 2 are attract-
ing more and more attention of chemists 
and pharmacologists due to the wide spec-
trum of their biological activity [6–9]. GA 
and GLA are active against a wide range 
of viruses, including herpes, corona, alpha, 
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flaviviruses and others [10]. At the same 
time, GA, GLA and their derivatives ex-
hibit a wide spectrum of antiviral activity 
both in the form of individual substances 
[1, 10] and in combination with antiviral 
drugs [11]. GA 1, due to its amphiphilic-
ity, can form supramolecular complexes 
with various hydrophobic molecules, sig-
nificantly increasing their solubility. This 
property was used in the approach of acad. 
G. A. Tolstikov: to reduce therapeutic doses 
of drugs and prolong the action [12–13]. 
In this regard, the presented work considers 
the possibilities of synthesizing new supra-
molecular complexes of GA and GLA with 
new antiviral drug Camphecene for the de-
velopment of low-dose pharmaceutical sub-
stances on their basis. The authors consider 
that these pharmaceutical substances can be 
used to suppress the multiplication of virus-
es in the early stages. Camphecene 3 (Fig. 1), 
has a broad spectrum of antiviral activity. 
It is proved to be active against influenza 
A strains and type B virus [14].
Experimental
For the  research we used GA and 
18β-GLA from Aldrich. Camphecene 
was synthesized at  the Novosibirsk In-
stitute of  Organic Chemistry (NIOCH 
SB RAS) and kindly provided by  Prof. 
N. F. Salakhutdinov. Solvents from Merck, 
HPLC/MS qualifications. The complexes 
were obtained by traditional mixing of so-
lutions with different molar ratios of GA, 
GLA, and Camph in a 70% aqueous-al-
coholic solution. The founding of com-
plexes of GA and GLA with Camph was 
recorded by UV/Vis spectroscopy using 
a  SPEKS SSP 705 spectrophotometer 
(190–1100 nm) (manufactured by CJSC 
Spectroscopic Systems, Russia). Measure-
ments were performed in a quartz cell. 
The formation of the complex was con-
sidered by the change in optical density 
at a constant concentration of Camph (C = 
0.5 mM). In order to exclude the contribu-
tion of the absorption of triterpenes by GA 
and GLA, respectively, their absorption 
spectrum was subtracted from the total 
spectrum. 
The  composition of  supramolecular 
complexes of GA and GLA with Camph 
was investigated with direct injection on 
a  Bruker Daltonics micrOTOF-Q mass 







































COOH2 : R = H
1 : R =
a) GA (1) b) GLA (2) c) Camph (3)
 Fig. 1. Formulae of a) glycyrrhetinic acid (2), С30Н46О4;  
b) glycyrrhizic acid (1), C42H62O16; c) Camphecene (3), C12H21NO
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tion. The micrOTOFcontrolTM2.2 software 
was used to analyze the results. The mass 
spectrometer was calibrated using a Fluka 
Electrospray Calibrant Solution. Detection 
of negative and positive ions was performed 
in the range of m/z from 50 to 3000.
Results and discussion
In  accordance with the  objectives 
of the work, sets of complexes of licorice 
triterpenes GA and GLA with an antiviral 
drug Camphecene at different molar ratios 
“guest:host” were synthesized.
In the first step, complexes of GA with 
Camph were obtained at molar ratios: 1:1 
and 2:1 and studied by UV / Vis spectros-
copy and mass spectrometry with elec-
trospray ionization. As demonstrated in 
Fig. 2, with an increase in the concentra-
tion of GA from 0 to 1 mM, a bathochro-
mic shift of  the  absorption maximum 
of Camph (201 → 212 nm) is recorded 
in the UV / Vis spectra, and a decrease 
in optical density is observed.
An increase in the concentration of GA 
(from 1.5 mM and higher) leads to the dis-
appearance of the maximum absorption 
of Camph, which indicates the complete 
binding of Camph molecules in the pres-
ence of GA (Fig. 3).
From the dependence of  the optical 
density on the concentration of glycyr-
rhizic acid (Fig. 3), over the entire range 
of increase in the concentration of GA, 
the value of the maximum optical density 
of Camph decreases.
The study of GLA as a complexing agent 
demonstrated similarchanges in the UV / 
Vis spectra of  the obtained complexes. 
When the  GLA concentration changes 
in  the  range from 0.05 to  0.125  mM, 
a bathochromic shift of  the absorption 
maximum of Camph is recorded (201 → 
206 nm). 
To  calculate the  stability constant 
of  the  complexes, we used the  Benesi-
Hildebrand plot (1) [15]. The  stability 
constant of the nGA-Camph complex was 
estimated from the change in the optical 
density of Camph (λmax1 = 201 nm) at its 
fixed concentration in solutions in which 
the GA (or GLA) concentration was var-
ied. Eq. (1) allows, within the framework 
of one experiment, not only to estimate 
the stability constant of the complex (K), 
Fig. 2. Absorption spectrum of Camphecene (CCamph = 0.5 mM)  
at different concentrations of GA
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but also to determine the stoichiometry 
ratio “host:guest” (n) in the complex:
 D/∆D – 1 = (1/[GA]n) ∙ (1/K), (1)
where ∆D = ∆ε∙[СCamph]  — change 
in the optical density of the solution, аnd 
К — the constant of stability of the com-
plex, determined for the reaction:
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The absorption spectrum of Camph 
was recorded at a wavelength of 201 nm, 
while the Camph concentration was con-
stant and amounted to 0.5 mM. The ob-
tained dependence of the absorption in-
tensity of Camphecene (λ = 201 nm) on 
the concentration of GA is shown in Fig. 4.
From the  slope of  the  straight-line 
D/DD, depending on 1/[GA]2 (Fig.  4), 
the stability constant of the complex was 
calculated using Eq. (1). The stability con-
stant for the Camph + GA complex is 1/K 
= 1.44 · 10–7 M2 or K = 6.94 · 106 M–2.
Recognizing the value of the binding 
constant, the change in the Gibbs energy 
was calculated. Obtained from the binding 
constant, the change in Gibbs energy ∆G 
= –38.4 kJ. Based on the obtained negative 
value, it can be concluded that the reaction 
proceeds spontaneously during the forma-
tion of GA and Camph complexes. Similarly, 
according to the Eq. (1), the stability con-
stant of the complex Camph+GLA was cal-
culated, 1/K = 3.46 · 10–7 M2 or K = 2.89 · 106 
M–2. Using the value of the binding constant, 
the change in Gibbs energy was calculated. 
The change in the Gibbs energy ∆G = –36.2 
kJ, which allows us to conclude that the reac-
tion proceeds spontaneously during the for-
mation of a complex of GLA with Camph.
The formation of complexes of Cam-
phecene with natural triterpenoids has also 
been studied using electrospray ionization 
mass spectrometry (ESI MS). In the mass 
spectra of complexes of GA and GLA with 
Camph in the mode of positive ions, both 
the peaks of GA, GLA, and Camph ions and 
the peaks of heterocomplexes containing 
GA and Camph or GLA and Camph are 
recorded.
Thus, in the GLA and Camph complex-
es synthesized both at a ratio of the com-
ponents of GLA and Camph in 1:1 and 
at a ratio of 2:1, a peak with m/z 688.73 
was recorded, corresponding to a single 
charged ion of  the  complex GLA and 
Camph [MGLA + MCamph + Na]
+. A typical 
mass spectrum of the GLA-Camph com-
plex is shown in Fig. 5.
The presence of peaks of heterocom-
plexes containing GA and Camph, GLA 
and Camph confirm the formation of com-
plexes of GA and GLA with Camph, re-
spectively. The results obtained demon-
Fig. 3. Dependence of optical density on 
the concentration of glycyrrhizic acid
Fig. 4. Dependence of the absorption 
intensity of Camphecene (λ = 201 nm) on 
the concentration of GA
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strate the  high potential of  triterpenes 
GA and GLA in the development of new 
pharmaceutical forms using the example 
of Camphecene in the form of molecular 
complexes.
Conclusions
In  the  presented work, complexes 
of pentacyclic triterpenes of the licorice 
(glycyrrhizic acid (GA) and glycyrrhetinic 
acid (GLA), its aglycone) with the antiviral 
drug Camphecene (Camph) were synthe-
sized and studied.
The complexes obtained at different 
molar ratios “host — GA (GLA): guest — 
Camph”: 1:1 and 2:1 were studied using 
both UV / Vis spectrophotometry and mass 
spectrometry with electrospray ionization. 
Formation of  the host:guest complexes 
were registered: GA and GLA molecules 
form molecular complexes (Camph+2GA; 
Camph+2GLA) with stability constants 
K = 6.94 · 106 М–2 and K = 2.89 · 106 М–2, 
respectively.
In the mode of positive ion, the mass 
spectra of mixture of GA and GLA with 
Camph showed peaks of GA, GLA, and 
Camph ions and the peaks of heterocom-
plexes containing GA and Camph, and 
GLA and Camph, respectively. The  re-
search results demonstrated the consid-
erable potential of ESI MS as a technique 
for simple and fast detection of formation 
of the complexes of GA /GLA and the nov-
el drugs.
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